HOXC4

homeobox C4, the group of HOXL subclass homeoboxes

Basic information

Region (hg38): 12:54016931-54056030

Previous symbols: [ "HOX3", "HOX3E" ]

Links

ENSG00000198353NCBI:3221OMIM:142974HGNC:5126Uniprot:P09017AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HOXC4 gene.

  • not_specified (33 variants)
  • not_provided (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXC4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000153633.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
2
clinvar
3
missense
33
clinvar
33
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 34 2 0
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HOXC4protein_codingprotein_codingENST00000609810 239099
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1680.8191257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6331331550.8570.000007281703
Missense in Polyphen2453.1750.45134620
Synonymous0.3526568.70.9460.00000348519
Loss of Function2.15310.60.2844.60e-7114

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005780.0000578
Ashkenazi Jewish0.000.00
East Asian0.0001100.000109
Finnish0.00004620.0000462
European (Non-Finnish)0.00002670.0000264
Middle Eastern0.0001100.000109
South Asian0.000.00
Other0.0003360.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.;
Pathway
Activation of anterior HOX genes in hindbrain development during early embryogenesis (Consensus)

Recessive Scores

pRec
0.156

Intolerance Scores

loftool
0.162
rvis_EVS
0.39
rvis_percentile_EVS
76.05

Haploinsufficiency Scores

pHI
0.246
hipred
Y
hipred_score
0.761
ghis
0.519

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.903

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hoxc4
Phenotype
muscle phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; digestive/alimentary phenotype;

Gene ontology

Biological process
skeletal system development;anterior/posterior pattern specification;positive regulation of transcription by RNA polymerase II;embryonic skeletal system morphogenesis;cartilage development
Cellular component
nucleus
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;activating transcription factor binding;HMG box domain binding